Silence Therapeutics
Price & Volume
Stats
See more52W Range | $1.97-$19.88 |
Market Cap | $247.9M |
Shares Short | 808,615 |
Financials
See moreRevenue (12 Mos) | $27.1M |
Revenue Growth (YoY) | -70.4% |
Gross Profit (12 Mos) | $21.3M |
Diluted EPS | -$1.68 |
News
See moreYahoo Finance • 2 years ago
Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues
Yahoo Finance • 2 years ago
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
Yahoo Finance • 2 years ago
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Investor Conference
Yahoo Finance • 3 years ago
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
About
CEO | Mr. Craig A. Tooman M.B.A. |
CFO | Ms. Rhonda L. Hellums |
Address | 72 Hammersmith Road, London, United Kingdom, W14 8TH |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 116 |
